Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial register · Germany

Metastatic Pancreatic Ductal Adenocarcinoma Trials in Germany, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5082 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:18 UTC
5082
Studies in scope
all four open statuses
2886
Recruiting now
open to new participants
989
Lead sponsors
across recruiting studies
Top sites
München 1 Düsseldorf 1 Dresden 1 Leipzig 1 Berlin 1
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Metastatic Pancreatic Ductal Adenocarcinoma trials in Germany

2 of 5082 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Pfizer
Phase 2/3
982
München, Düsseldorf, Dresden, Leipzig, Berlin
2025-10-03
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Bochum, Frankfurt am Main, Hamburg, Hanover, Heilbronn, Magdeburg, Riesa, Ulm
2024-12-13
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-germany/condition/metastatic-pancreatic-ductal-adenocarcinoma

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,082 studies in total at the last sync on 17 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies listing the condition Metastatic Pancreatic Ductal Adenocarcinoma.

How many Metastatic Pancreatic Ductal Adenocarcinoma trials are recruiting in Germany?

1 of the 2 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Metastatic Pancreatic Ductal Adenocarcinoma), 2 studies
PhaseStudiesRecruitingShare
Phase 2/31150%
Phase 31050%

Most active sponsors

Lead sponsors with the most studies (Metastatic Pancreatic Ductal Adenocarcinoma)
Lead sponsorStudiesRecruiting
Arcus Biosciences, Inc.10
Pfizer11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.